Skip to content
Geographic · Net Sales

Int'l — Net Sales

Boston Scientific Int'l — Net Sales increased by 1.0% to $1.92B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.8%, from $1.7B to $1.92B. Over 4 years (FY 2021 to FY 2025), Int'l — Net Sales shows an upward trend with a 9.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful international market expansion, strong global demand for the company's product portfolio, or effective local distribution strategies. A decrease may signal increased international competition, regulatory hurdles, or unfavorable currency exchange rate impacts.

Detailed definition

This metric represents the total revenue generated from the sale of medical devices and related services within internat...

Peer comparison

Peers in the medical device industry typically report international revenue as a percentage of total sales to demonstrate global diversification and exposure to emerging market growth rates.

Metric ID: bsx_segment_int_l_net_sales

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.28B$1.21B$1.33B$1.25B$1.31B$1.24B$1.32B$1.39B$1.49B$1.43B$1.51B$1.6B$1.65B$1.62B$1.67B$1.7B$1.84B$1.77B$1.9B$1.92B
QoQ Change-5.6%+10.2%-6.1%+5.0%-5.7%+6.5%+5.3%+7.5%-4.2%+6.0%+5.7%+3.4%-2.3%+3.3%+2.0%+7.9%-3.6%+7.4%+1.0%
YoY Change+2.7%+2.5%-1.0%+11.1%+13.7%+15.5%+15.0%+15.4%+11.0%+13.2%+10.3%+6.4%+11.1%+9.5%+13.9%+12.8%
Range$1.21B$1.92B
CAGR+9.0%
Avg YoY Growth+10.2%
Median YoY Growth+11.1%
Current Streak2 quarters growth

Frequently Asked Questions

What is Boston Scientific's int'l — net sales?
Boston Scientific (BSX) reported int'l — net sales of $1.92B in Q1 2026.
How has Boston Scientific's int'l — net sales changed year-over-year?
Boston Scientific's int'l — net sales increased by 12.8% year-over-year, from $1.7B to $1.92B.
What is the long-term trend for Boston Scientific's int'l — net sales?
Over 4 years (2021 to 2025), Boston Scientific's int'l — net sales has grown at a 9.7% compound annual growth rate (CAGR), from $4.98B to $7.21B.
What does int'l — net sales mean?
The total revenue earned from medical device sales in all geographic regions outside the company's home country.